Alexander W. Hird

2.1k total citations
19 papers, 1.1k citations indexed

About

Alexander W. Hird is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Alexander W. Hird has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Alexander W. Hird's work include Synthetic Organic Chemistry Methods (5 papers), Cell death mechanisms and regulation (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Alexander W. Hird is often cited by papers focused on Synthetic Organic Chemistry Methods (5 papers), Cell death mechanisms and regulation (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Alexander W. Hird collaborates with scholars based in United States, United Kingdom and Brazil. Alexander W. Hird's co-authors include Amir H. Hoveyda, Adriana E. Tron, M. Kevin Brown, Kang-Sang Lee, Monica A. Kacprzynski, Michelle L. Lamb, Brian Aquila, Qibin Su, Matthew A. Belmonte and Claudio Chuaqui and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Alexander W. Hird

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander W. Hird United States	15	748	452	255	143	91	19	1.1k
Gretchen M. Schroeder United States	15	898 1.2×	377 0.8×	303 1.2×	307 2.1×	19 0.2×	26	1.4k
Mark Cornebise United States	11	203 0.3×	207 0.5×	120 0.5×	140 1.0×	34 0.4×	12	606
Martin Michels Germany	15	389 0.5×	455 1.0×	169 0.7×	108 0.8×	41 0.5×	27	939
Jasna Maksimoska United States	15	496 0.7×	598 1.3×	131 0.5×	605 4.2×	76 0.8×	20	1.2k
Ekaterina Yu. Rybalkina Russia	18	360 0.5×	318 0.7×	76 0.3×	239 1.7×	17 0.2×	72	819
Brendan Frett United States	20	531 0.7×	493 1.1×	39 0.2×	190 1.3×	73 0.8×	53	1.0k
Renaud Prudent France	18	186 0.2×	687 1.5×	82 0.3×	188 1.3×	62 0.7×	37	1.1k
Brian L. Hodous United States	10	573 0.8×	291 0.6×	171 0.7×	58 0.4×	29 0.3×	15	880
John I. Trujillo United States	12	491 0.7×	457 1.0×	34 0.1×	147 1.0×	37 0.4×	26	883
Weifang Tang China	19	805 1.1×	351 0.8×	32 0.1×	78 0.5×	37 0.4×	47	1.1k

Countries citing papers authored by Alexander W. Hird

Since Specialization

Citations

This map shows the geographic impact of Alexander W. Hird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander W. Hird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander W. Hird more than expected).

Fields of papers citing papers by Alexander W. Hird

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander W. Hird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander W. Hird. The network helps show where Alexander W. Hird may publish in the future.

Co-authorship network of co-authors of Alexander W. Hird

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander W. Hird. A scholar is included among the top collaborators of Alexander W. Hird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander W. Hird. Alexander W. Hird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Hargreaves, David, Rodrigo J. Carbajo, Michael S. Bodnarchuk, et al.. (2023). Design of rigid protein–protein interaction inhibitors enables targeting of undruggable Mcl-1. Proceedings of the National Academy of Sciences. 120(21). e2221967120–e2221967120. 5 indexed citations

2.

Guo, Yue, Aleksey B. Rogov, Alexander W. Hird, et al.. (2021). Plasma electrolytic oxidation of magnesium by sawtooth pulse current. Surface and Coatings Technology. 429. 127938–127938. 26 indexed citations

3.

Oliveira, Taianá Maia de, et al.. (2020). The structure of human GCN2 reveals a parallel, back-to-back kinase dimer with a plastic DFG activation loop motif. Biochemical Journal. 477(1). 275–284. 17 indexed citations

4.

Hird, Alexander W. & Adriana E. Tron. (2019). Recent advances in the development of Mcl-1 inhibitors for cancer therapy. Pharmacology & Therapeutics. 198. 59–67. 106 indexed citations

5.

Balazs, Amber, Rodrigo J. Carbajo, Nichola L. Davies, et al.. (2019). Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles. Journal of Medicinal Chemistry. 62(21). 9418–9437. 23 indexed citations

6.

Barlaam, Bernard, Chris De Savi, Lisa Drew, et al.. (2018). Abstract 1650: Discovery of AZD4573, a potent and selective inhibitor of CDK9 that enables transient target engagement for the treatment of hematologic malignancies. Cancer Research. 78(13_Supplement). 1650–1650. 5 indexed citations

7.

Yang, Bin, Melissa M. Vasbinder, Alexander W. Hird, et al.. (2018). Adventures in Scaffold Morphing: Discovery of Fused Ring Heterocyclic Checkpoint Kinase 1 (CHK1) Inhibitors. Journal of Medicinal Chemistry. 61(3). 1061–1073. 20 indexed citations

8.

Hird, Alexander W., J. Paul Secrist, Ammar Adam, et al.. (2017). Abstract DDT01-02: AZD5991: A potent and selective macrocyclic inhibitor of Mcl-1 for treatment of hematologic cancers. Cancer Research. 77(13_Supplement). DDT01–2. 15 indexed citations

9.

Belmonte, Matthew A., Brian Aquila, Claudio Chuaqui, et al.. (2016). Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain. Nature Chemical Biology. 12(11). 931–936. 162 indexed citations

10.

Hird, Alexander W., Brian Aquila, Edward J. Hennessy, Melissa M. Vasbinder, & Bin Yang. (2015). Small molecule inhibitor of apoptosis proteins antagonists: a patent review. Expert Opinion on Therapeutic Patents. 25(7). 755–774. 16 indexed citations

11.

Hird, Alexander W., Brian Aquila, M. Block, et al.. (2014). Structure-based design and synthesis of tricyclic IAP (Inhibitors of Apoptosis Proteins) inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(7). 1820–1824. 4 indexed citations

12.

Belmonte, Matthew A., et al.. (2014). Evaluation of Mcl-1 Inhibitors in Preclinical Models of Multiple Myeloma. Blood. 124(21). 3428–3428. 2 indexed citations

13.

Dakin, Les A., M. Block, Huawei Chen, et al.. (2012). Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases. Bioorganic & Medicinal Chemistry Letters. 22(14). 4599–4604. 85 indexed citations

14.

Yang, Bin, Alexander W. Hird, Daniel Russell, et al.. (2012). Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMO. Bioorganic & Medicinal Chemistry Letters. 22(14). 4907–4911. 15 indexed citations

15.

Lee, Kang-Sang, M. Kevin Brown, Alexander W. Hird, & Amir H. Hoveyda. (2006). A Practical Method for Enantioselective Synthesis of All-Carbon Quaternary Stereogenic Centers through NHC-Cu-Catalyzed Conjugate Additions of Alkyl- and Arylzinc Reagents to β-Substituted Cyclic Enones. Journal of the American Chemical Society. 128(22). 7182–7184. 195 indexed citations

16.

Hird, Alexander W. & Amir H. Hoveyda. (2005). Catalytic Enantioselective Alkylations of Tetrasubstituted Olefins. Synthesis of All-Carbon Quaternary Stereogenic Centers through Cu-Catalyzed Asymmetric Conjugate Additions of Alkylzinc Reagents to Enones. Journal of the American Chemical Society. 127(43). 14988–14989. 117 indexed citations

17.

Hoveyda, Amir H., Alexander W. Hird, & Monica A. Kacprzynski. (2004). Small peptides as ligands for catalytic asymmetric alkylations of olefins. Rational design of catalysts or of searches that lead to them?. Chemical Communications. 1779–1779. 143 indexed citations

18.

Hird, Alexander W. & Amir H. Hoveyda. (2003). Cu‐Catalyzed Enantioselective Conjugate Additions of Alkyl Zinc Reagents to UnsaturatedN‐Acyloxazolidinones Promoted by a Chiral Triamide Phosphane. Angewandte Chemie International Edition. 42(11). 1276–1279. 91 indexed citations

19.

Hird, Alexander W. & Amir H. Hoveyda. (2003). Cu‐Catalyzed Enantioselective Conjugate Additions of Alkyl Zinc Reagents to UnsaturatedN‐Acyloxazolidinones Promoted by a Chiral Triamide Phosphane. Angewandte Chemie. 115(11). 1314–1317. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact